The makers of Vytorin®, Merck/Schering-Plough Pharmaceuticals, recently issued a controversial press release about the Enhance Study that compared the effects of Vytorin® (a combination of simvastatin and ezetimibe, brand name Zetia®) vs. just simvastatin.
No substantial difference was observed with the addition of Zetia®, perhaps even a negative effect. The news has triggered a media frenzy.
The New York Times headlined the story, "Drug Has No Benefit in Trial." "Drug doesn't slow...
...trying to kill me) and it is cheap. It also shifts LDL particle size toward the less deadly... Read more »
...above steps to take place. Knowing your LDL and HDL particle size gives you a better overview... Read more »
...removed from the body in the bile. Measuring for particle size and particle number is the... Read more »
Jack had been told again and again that there was absolutely nothing wrong with his cholesterol... Read more »
Just yesterday I got my first home cholesterol and triglyceride test results. It took three weeks... Read more »
Learn about how doctors measure bone density.... Read more »
(Ivanhoe Newswire) -- A handful of pistachios a day may help you fight heart disease. A new study from Penn State reveals 1.5 to three ounces of the... Read summary »
(Ivanhoe Newswire) A gene variation may be why cholesterol-lowering drugs don't work in some people. The gene variation, called alternative... Read summary »
(Ivanhoe Newswire) -- Some doctors are calling for people to have more control over their own heart health by allowing statins, medications now... Read summary »
(Ivanhoe Newswire) -- With an obesity epidemic brewing among U.S. children, there is concern that overweight and obese children need to be screened... Read summary »
(Ivanhoe Newswire) -- One of the hottest diet trends of the past decade is back, but this time, meat is taking a backseat to vegetables. New research... Read summary »